Begin main content

Reports

We found 6672 result(s)

2020 CADTH Symposium

Event Date: April 19, 2020 - April 21, 2020
Result type: Events

Join us in Toronto for the 2020 CADTH Symposium. Connect with Canadian and international experts in the objective assessment and evaluation of health technologies for three days of education, information sharing, and networking. Mark your calendar: 2020 CADTH Symposium
April 19 to 21, 2020
Sheraton Centre Toronto
Toronto, On...

Non-Pharmacological Interventions for Chronic Non-Cancer Pain: Acupuncture

Event Date: March 16, 2020
Result type: Events

Because of the prevalence and burden of chronic pain, and the associated opioid crisis in our country, health professionals are looking for non-pharmacological treatment options to recommend to their patients. Join CADTH for a webinar on the current evidence on acupuncture for chronic non-cancer pain. The target audience for this presentation i...

cabotegravir/rilpivirine (TBC)

Last Updated: January 29, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: cabotegravir-rilpivirine cabotegravir sodium
Indications: HIV-1 infection

  • Brand Name: TBC
  • Manufacturer: ViiV Healthcare ULC
  • Project Number: SR0628-000
  • Project Status: Active
  • Submission Type: New Combination

esketamine hydrochloride (TBC )

Last Updated: January 29, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: esketamine hydrochloride
Indications: Major depressive disorder (MDD), adults

  • Brand Name: TBC
  • Manufacturer: Janssen Inc.
  • Project Number: SR0621-000
  • Project Status: Active
  • Submission Type: New

ustekinumab (Stelara/Stelara I.V)

Last Updated: January 29, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: ustekinumab
Indications: Ulcerative colitis

  • Brand Name: Stelara/Stelara I.V
  • Manufacturer: Janssen Inc.
  • Project Number: SR0627-000
  • Project Status: Active
  • Submission Type: New Indication

certolizumab pegol (Cimzia)

Last Updated: January 29, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: certolizumab pegol
Indications: Psoriasis, moderate to severe plaque

  • Brand Name: Cimzia
  • Manufacturer: UCB Canada Inc.
  • Project Number: SR0587-000
  • Project Status: Active
  • Submission Type: New Indication

tafamidis (Vyndaqel)

Last Updated: January 28, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: tafamidis
Indications: transthyretin-mediated amyloidosis

  • Brand Name: Vyndaqel
  • Manufacturer: Pfizer Canada
  • Project Number: SR0625-000
  • Project Status: Active
  • Submission Type: New

Hybrid Closed-Loop Insulin Delivery Systems for People with Type 1 Diabetes

Last Updated: January 29, 2020
Result type: Reports
Product Line: Optimal Use

Hybrid closed-loop insulin delivery systems (HCLs) are a new technology for the management of type 1 diabetes. HCLs combine an insulin pump with a continuous glucose monitor (CGM) and a computer program. Together these use information from the CGM to automatically determine insulin needs throughout the day and keep the user within a pre-determin...

  • Project Number: OP0548-000

safinamide (Onstryv)

Last Updated: January 28, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: safinamide
Indications: Parkinson's disease

  • Brand Name: Onstryv
  • Manufacturer: Valeo Pharma Inc.
  • Project Number: SR0617-000
  • Project Status: Active
  • Submission Type: New

belimumab (Benlysta )

Last Updated: January 28, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: Belimumab
Indications: systemic lupus erythematosus

  • Brand Name: Benlysta
  • Manufacturer: GlaxoSmithKline Inc.
  • Project Number: SR0616-000
  • Project Status: Active
  • Submission Type: New